fill
Listen On
Gastroenterology

What is the role of IL23/IL17 axis in IBD

Amy Stewart, ARNP, from Capital Digestive Care, explains the role of the IL-23/IL-17 axis in inflammatory bowel disease (IBD). Learn how these cytokines drive chronic inflammation and their significance in IBD pathogenesis, as well as how targeted therapies address these pathways.

Related FAQ Video Module

faqimg

What role does a new mechanism of action play in your prescribing decisions of IBS-C therapy?

faqimg

Describe the IL23/IL17 axis

faqimg

What is the Difference Between Biosimilars and Generics?

faqimg

What resources do you use to understand the latest approaches to managing IBS-C patients?

faqimg

Best practices in determining clinically meaningful “response” to therapy for IBS-C patients?

faqimg

Best practices to accelerate the time to finding the right therapy for your patients with IBS-C?

faqimg

What does it mean for a biosimilar to be interchangeable and why is that important?

VIEW ALL
sectionimg
dotimg

Download the app and start using it now

appstore Download on the App Store playstore GET IT ON Google Play

© 2024 Gastroenterology & Hepatology Advance Practice Providers, All rights reserved.